Morinda elliptica
Morinda elliptica · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Morinda elliptica is a versatile medicinal plant known for its significant therapeutic potential in traditional healing. The leaves and roots of this species serve as primary sources for extracting bioactive compounds. Rich in chemical constituents such as coumarins, flavonoids, tannins, and nordamnacanthal, the plant offers diverse pharmacological benefits. Research suggests these components contribute to vital activities, including powerful anticancer properties. Furthermore, the plant is frequently utilized in managing health conditions such as gout.
- Synonyms
- Morinda Citrifolia Var. Elliptica
- Common names
- Not available
- Family
- Rubiaceae
- Distribution
- Southern America
- Plant Parts
- Leaf · Root
Classification
Common Names
Morinda elliptica is a distinctive plant widely recognized by its diverse regional names. In Thailand, it is commonly referred to as ยอป่า, reflecting its local identity and traditional significance. Similarly, the species is known by the Chinese common name 橢圓葉巴戟. These various names highlight the plant's widespread distribution across different cultures and linguistic landscapes. Understanding these various identifiers is essential for anyone studying the botanical diversity of the region.
Sources: Catalogue of Life (COL)
Synonyms
Morinda elliptica is a botanical species that is frequently encountered in various scientific discussions. Within taxonomic literature, this plant is recognized by the synonym Morinda citrifolia var. elliptica. This relationship highlights the intricate ways in which different varieties are classified within the same genus. Understanding these nomenclature connections is essential for researchers seeking to accurately identify the specimen. Consequently, recognizing these synonymous links ensures clarity when studying the plant's unique characteristics.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Morinda elliptica is a distinguished member of the kingdom Plantae. Within this vast biological realm, the plant is classified under the class Equisetopsida. It belongs to the order Gentianales, which helps define its specific evolutionary lineage. Furthermore, this species is situated within the family Rubiaceae. Ultimately, it is identified by its unique botanical placement within the genus Morinda.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Gentianales |
| Family | Rubiaceae |
| Genus | Morinda |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Morinda elliptica is a plant species with a widespread distribution across several tropical regions in Asia. Its presence is well-documented throughout Indo-China, specifically spanning across territories such as Myanmar and Thailand. Beyond these mainland areas, the species also extends its reach into the Malesia region. This includes significant coverage within Malaya, showcasing its adaptability to diverse tropical environments. Together, these locations highlight the broad ecological footprint this plant maintains throughout the Asian tropics.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Morinda elliptica typically manifests as a versatile shrub characterized by its distinct growth form. Under optimal conditions, this species can reach a significant maximum height of 16 meters.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Morinda elliptica has demonstrated significant anticancer potential through the bioactive compounds damnacanthal and nordamnacanthal isolated from its roots. Research indicates that these specific compounds exhibit strong cytotoxic properties when tested against T-lymphoblastic leukemia cell lines. While both substances work toward inhibiting cancer cells, they utilize different mechanisms, such as inducing apoptosis or causing arrest at the G0/G1 phase of the cell cycle. Molecular analysis reveals that these processes involve complex actions like internucleosomal DNA cleavage and the activation of specific endonucleases. Ultimately, these findings suggest that derivatives from this plant could serve as promising candidates for future leukemia treatments.
Compounds
Morinda elliptica is a notable medicinal plant recognized for its diverse array of natural bioactive compounds. Research indicates that this species contains essential phytochemicals such as flavonoids, coumarins, and tannin. Furthermore, the plant is a significant source of apigenin, which contributes to its complex chemical profile. Studies also highlight the presence of nordamnacanthal within its roots, a compound with significant biological activity. Together, these various constituents underscore the therapeutic potential of the plant in addressing different health conditions.
Conditions
Morinda elliptica demonstrates significant medicinal potential by treating T-lymphoblastic leukemia, specifically the CEM-SS cell line, through the anticancer properties of its root compounds damnacanthal and nordamnacanthal. The plant also shows efficacy in treating the blood stage of chloroquine-resistant P. falciparum, as its leaf extracts exhibit promising antiplasmodial activity. Additionally, Morinda elliptica serves as a treatment for gout due to its high xanthine oxidase inhibitory activity driven by various bioactive compounds. Its antioxidant capabilities are further evidenced by its high performance in a superoxide scavenging assay. These diverse biological activities highlight the plant's therapeutic versatility in addressing cancer, malaria, inflammation, and oxidative stress.
Preparations
Parts used
Morinda elliptica serves as a significant subject of pharmacological research due to the diverse therapeutic potential found within its different anatomical structures. Studies have demonstrated that the leaf extracts of this species exhibit promising antiplasmodial activities against chloroquine-resistant strains of Plasmodium falciparum. Furthermore, the plant's roots contain potent bioactive compounds, specifically nordamnacanthal and damnacanthal, which demonstrate significant anticancer properties. These root-derived substances have shown the ability to induce apoptosis and cell cycle arrest in T-lymphoblastic leukemia cells. Consequently, both the leaves and roots of Morinda elliptica represent valuable sources for the discovery of new medicinal treatments.